Skip to main content

Table 5 Laboratory parameters and vital signs of all patients

From: Long-term observational study in Japanese hemodialysis patients who completed a 3-year clinical study of lanthanum carbonate

Parameters

Start

4 years after

8 years after

4 years mean change ± SEM (95 % CI)

8 years mean change ± SEM (95 % CI)

P (mg/dL)

7.8 ± 1.6

5.8 ± 1.0***

5.3 ± 1.2***

−2.19 ± 0.29 (−2.80, −1.59)***

−.51 ± 0.35 (−3.24, −1.79)***

Corrected Ca (mg/dL)

9.3 ± 0.6

9.2 ± 0.5

9.4 ± 0.6

−0.11 ± 0.13 (−0.38, 0.16)

0.11 ± 0.11 (−0.12, 0.34)

Intact PTH (pg/mL)

283.1 ± 152.4

180.7 ± 126.6***

179.1 ± 131.7*

−103.95 ± 27.20 (−160.55, −47.35)***

−103.45 ± 43.91 (−194.76, −12.14)*

Na (mEq/L)

139.2 ± 3.0

138.5 ± 2.4

138.3 ± 3.3*

−0.89 ± 0.62 (−2.17, 0.38)

−1.20 ± 0.66 (−2.56, 0.16)*

K (mEq/L)

5.0 ± 0.7

5.4 ± 0.7

5.0 ± 0.8

0.39 ± 0.10 (0.19, 0.60)

−0.05 ± 0.13 (−0.33, 0.22)

Cl (mEq/L)

100.8 ± 3.4

102.9 ± 3.6

102.0 ± 3.4

1.85 ± 0.79 (0.23, 3.47)

1.07 ± 0.83 (−0.63, 2.78)

Glucose (mg/dL)

128.6 ± 51.9

123.9 ± 53.3

113.9 ± 37.2

17.00 ± 23.91 (−37.08, 71.08)

2.90 ± 8.10 (−15.43, 21.23)

CRP (mg/dL)

0.2 ± 0.2

0.6 ± 1.3

0.6 ± 1.0

0.29 ± 0.19 (−0.11, 0.70)

0.37 ± 0.22 (−0.09, 0.83)

RBC (×104/μL)

327 ± 39

356 ± 32

361 ± 36

0.31 ± 0.08 (0.15, 0.47)

0.34 ± 0.08 (0.18, 0.50)

WBC (/μL)

5803 ± 1474

6190 ± 2028

5891 ± 1977

0.44 ± 0.28 (−0.13, 1.01)

0.16 ± 0.27 (−0.40, 0.71)

Hb (g/dL)

10.5 ± 1.1

11.2 ± 1.3

10.8 ± 1.1

0.48 ± 0.26 (−0.04, 1.01)

0.26 ± 0.26 (−0.28, 0.79)

Ht (%)

31.8 ± 3.6

34.7 ± 2.6

33.9 ± 2.6

3.00 ± 0.73 (1.51, 4.51)

2.06 ± 0.70 (0.62, 3.49)

Plt (×104/μL)

19.8 ± 4.4

19.7 ± 6.6

20.2 ± 6.7

0.03 ± 1.04 (−2.21, 2.18)

2.06 ± 0.70 (0.62, 3.49)

Serum Alb (g/dL)

4.0 ± 0.3

3.9 ± 0.3*

3.6 ± 0.3***

−0.13 ± 0.05 (−0.23, −0.02)*

−0.43 ± 0.06 (−0.56, −0.31)***

ALP (U/L)

237.3 ± 110.1

242.6 ± 85.0

262.9 ± 95.1

2.19 ± 18.32 (−35.54, 39.92)

10.88 ± 17.59 (−25.34, 47.12)

LDH (IU/L)

168.0 ± 30.5

173.9 ± 33.5

195.5 ± 47.4

5.65 ± 6.52 (−7.86, 19.16)

23.91 ± 7.45 (8.46, 39.37)

AST (U/L)

11.7 ± 6.4

10.9 ± 4.2

17.8 ± 16.5

−0.85 ± 1.27 (−3.47, 1.76)

5.85 ± 3.31 (−0.95, 12.65)

ALT (U/L)

10.7 ± 5.5

10.3 ± 7.2

13.7 ± 8.5

−0.37 ± 1.76 (−3.99, 3.25)

2.85 ± 1.80 (−0.84, 6.55)

γ GTP (U/L)

20.5 ± 12.6

26.1 ± 31.5

28.2 ± 19.1

8.46 ± 6.75 (−5.51, 22.43)

9.38 ± 3.66 (1.81, 16.94)

Total bilirubin (mg/dL)

0.2 ± 0.1

0.3 ± 0.1

0.3 ± 0.1

0.04 ± 0.02 (−0.01, 0.09)

0.05 ± 0.03 (−0.01, 0.12)

Creatinine (mg/dL)

12.7 ± 2.0

12.3 ± 1.8

11.2 ± 2.0***

−0.30 ± 0.33 (−0.98, 0.37)

−1.40 ± 0.32 (−2.07, −0.74)***

Uric acid (mg/dL)

8.5 ± 1.2

8.0 ± 1.5

7.7 ± 1.4**

−0.44 ± 0.31 (−1.09, 0.21)

−0.84 ± 0.32 (−1.50, −0.17)**

BUN (mg/dL)

72.1 ± 12.0

69.6 ± 12.5

62.6 ± 16.6**

−0.99 ± 3.02 (−7.21, 5.22)

−9.81 ± 2.90 (−15.78, −3.84)**

BUN after dialysis (mg/dL)

23.6 ± 7.0

20.0 ± 5.7**

16.8 ± 6.0***

−3.85 ± 1.37 (−6.68, −1.02)**

−7.39 ± 1.32 (−10.1, −4.66)***

TG (mg/dL)

132.0 ± 66.0

121.8 ± 76.7

110.2 ± 46.3

10.53 ± 18.02 (−27.33, 48.38)

−5.11 ± 10.69 (−27.57, 17.36)

Total cholesterol (mg/dL)

178.0 ± 33.4

161.8 ± 37.9

171.0 ± 39.2

−7.56 ± 5.43 (− 19.13, 4.00)

−2.00 ± 8.45 (−20.01, 16.01)

HDL-C (mg/dL)

45.5 ± 14.4

51.0 ± 14.2

53.6 ± 16.9

5.16 ± 2.27 (0.40, 9.92)

6.42 ± 2.29 (1.62, 11.2)

SBP (mmHg)

160.2 ± 24.4

144.2 ± 21.4***

146.2 ± 18.5***

−19.13 ± 5.19 (−29.89, −8.37)***

−18.83 ± 4.81 (−28.80, −8.86)***

DBP (mmHg)

88.7 ± 16.5

79.6 ± 12.6**

77.4 ± 13.2***

−10.26 ± 3.69 (−17.92, −2.6)**

−13.39 ± 2.25 (−18.06, −8.73)***

HR (beats/min)

77.1 ± 12.0

74.8 ± 16.9

75.0 ± 13.3

−2.26 ± 2.79 (−8.13, 3.61)

−2.74 ± 3.00 (−9.04, 3.57)

  1. Data are given as mean ± standard deviation (n)
  2. CI confidence interval
  3. V.S. At the start, ***P < 0.001, **P < 0.01, *P < 0.05